Great Point Partners Acquires Majority Stake in Lenis Group

Kelso & Company Acquires Vālenz Health from Great Point Partners

June 21, 2023

Healthcare Services

Kelso & Company completed a majority equity investment in Vālenz Health, with Great Point Partners exiting after a six-year partnership. The capital infusion will support Valenz’s organic and acquisitive growth plans to expand its payment integrity, cost-containment and healthcare data capabilities; terms were not disclosed.

Vālenz Acquires Kozani Health

April 5, 2021

Healthcare Services

Vālenz, a Great Point Partners-backed healthcare platform, has acquired Kozani Health and integrated its bill review and claim management services as Valenz ProteKHt. The add-on expands Vālenz's payment integrity and claim management capabilities for self-funded and self-insured employers.

Equistone Partners Europe Invests in Ligentia

February 8, 2021

Logistics & Distribution

Equistone Partners Europe has made a minority growth investment in global supply chain management provider Ligentia; financial terms were not disclosed. The deal will support Ligentia’s strategic acquisition-led growth plans and further development of its proprietary supply‑chain platform, Ligentix, while founder Nick Jones and existing management remain invested and in operational control.

Great Point Partners Completes Growth Recapitalization of Velentium

September 29, 2021

Medical Devices

Great Point Partners completed a growth recapitalization of Houston-based Velentium, a professional engineering and contract medical device manufacturer. The investment will fund Velentium's expansion initiatives — including tuck-in acquisitions and enhanced engineering and manufacturing capabilities — while preserving the company's quality and culture.

LIAN Group Acquires Scientis to Expand Healthcare Platform

August 28, 2024

Healthcare Services

LIAN Group, an owner-operator investment firm, has acquired Scientis, a Swiss dermatology and cosmeceutical company known for its Cyspera pigment-correcting product line. The deal expands LIAN's Healthcare investment platform and aims to accelerate Scientis’ global growth, product development and market penetration across Asia, the United States and other markets.

LIAN Group Acquires Scientis to Expand Healthcare Platform

August 28, 2024

Healthcare Services

LIAN Group, through its Healthcare investment platform, has acquired Scientis, a Swiss cosmeceutical company known for its Cyspera pigment-correcting product line. The deal is intended to accelerate Scientis' global growth, expand LIAN's footprint into beauty and wellbeing, and support product and market development using LIAN's owner-operator capabilities.